Clinical trial
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients…
NCT00262795 · German CLL Study Group, Other · Completed
Key facts
| NCT number | NCT00262795 |
|---|---|
| Title | Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia |
| Official title | Fludarabine Versus Chlorambucil in First Line Therapy of Elderly Patients (More Than 65 Years) With Advanced Chronic Lymphocytic Leukemia |
| Lead sponsor | German CLL Study Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | Fludarabine, Chlorambucil |
| Enrollment | 206 |
| Start date | Sep 1, 2003 |
| Primary completion | Jan 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Dec 7, 2005 |
| Last update posted | May 23, 2019 |
| Countries | Austria, Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: